24/7 MarketNews

24/7 Market News Breaking News Alert

2018-04-26T17:30:18-04:00 Apr. 3, 2018 9:29AM EDT|

Notice: Republished due to missing disclaimer in previous press release

Kraig Biocraft Laboratories Successfully Produces Recombinant Spider Silk Cocoons from New Line of Hybrid Silkworms

ANN ARBOR, Mich., – April 3, 2018- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company has successfully produced the first recombinant spider silk cocoons from the new line of hybrid transgenic silkworms recently created at its Michigan production and research facility. This new hybrid line was created by combining one of the Company’s best performing recombinant spider silk lines with a commercial strain, resulting in the largest cocoons in the Company’s history. (For the full press release, please go to http://www.kraiglabs.com/kraig-biocraft-laboratories-successfully-produces-recombinant-spider-silk-cocoons-from-new-line-of-hybrid-silkworms/)

The first generation cocoons from this hybrid cross have exceeded the Company’s expectations with some cocoons nearly twice as large as the original spider silk line cocoons. These larger cocoons reduce operating and handling costs throughout the production process and yield longer silk threads. Mechanical performance testing of this new hybrid spider silk line is expected to begin shortly.

“Crossing our recombinant spider silk silkworm lines with larger traditional silkworm lines is an element of both our research roadmap and commercialization plans. The results we’ve seen from this first crossing confirm the benefits of those strategies,” said Jon Rice, COO. “The size of these new hybrids is beyond what we expected in a first generation hybrid and we are very interested to see how performance testing results compare to the original silkworm lines. We anticipate creating many additional hybrids, over the coming quarters, combining the performance of our spider silk lines with these larger commercial strains. We expect these efforts will increase our production efficiency and lower our cost to produce recombinant spider silk.”

Facebook to Announce First Quarter 2018 Results

MENLO PARK, Calif., April 2, 2018 /PRNewswire/ -- Facebook, Inc. (NASDAQ: FB) announced today that the company's first quarter 2018 financial results will be released after market close on Wednesday, April 25, 2018.

Facebook will host a conference call to discuss its results at 2 p.m. PT / 5 p.m. ET the same day. The live webcast of the call can be accessed at the Facebook Investor Relations website at investor.fb.com, along with the company's earnings press release, financial tables, and slide presentation.

Following the call, a replay will be available at the same website. A telephonic replay will be available for one week following the conference call at 404.537.3406 or 855.859.2056, Conference ID: 6068418.

(For the full press release, please go to http://www.prnewswire.com/news-releases/facebook-to-announce-first-quarter-2018-results-300622660.html)

Alibaba to Acquire Full Ownership of China Online Delivery Platform Ele.me

Acquisition will leverage Ele.me’s delivery force to boost Alibaba’s New Retail initiative in local services

Apr 1, 2018 11:13 p.m. ET Alibaba Group Holding Limited (NYSE: BABA) announced today that the company will acquire all outstanding shares that it does not already own in Ele.me, a leading online delivery and local services platform in China, in a transaction that implies the enterprise value of Ele.me at US$9.5 billion. Alibaba and its affiliate Ant Small and Micro Financial Services Group Co., Ltd. currently own approximately 43% of the outstanding voting shares of Ele.me.

This acquisition will deepen Ele.me’s integration into Alibaba’s ecosystem and advance Alibaba’s New Retail strategy to provide a seamless online and offline consumer experience in the local services sector.

(For the full press release, please go to https://www.businesswire.com/news/home/20180401005041/en/Alibaba-Acquire-Full-Ownership-China-Online-Delivery)

Connect with 24/7 Market News on social media:

On Twitter

On Facebook

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
About Facebook
Founded in 2004, Facebook's mission is to give people the power to build community and bring the world closer together. People use Facebook to stay connected with friends and family, to discover what's going on in the world, and to share and express what matters to them.
About Alibaba Group
Alibaba Group’s mission is to make it easy to do business anywhere. The company aims to build the future infrastructure of commerce. It envisions that its customers will meet, work and live at Alibaba, and that it will be a company that lasts at least 102 years.
24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. 24/7MN will not be buying, selling or trading in any of the above-listed stocks within 72 hours of the publication of this report. 24/7MN has covered Kraig Biocraft Laboratories, Inc. in the past and owns shares. You may view this as a conflict of interest. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. 24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For further information on 24/7 Market News, please go to www.247marketnews.com
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MSC undertakes no obligation to update such statements
24/7 Market News Editor@247marketnews.com

Send this to a friend

Hi, this may be interesting you: Kraig Biocraft Laboratories’ New R&D Facility Extends Its Competitive Advantages and Prepares for Large Scale Production! This is the link: https://www.247marketnews.com/kraig-biocraft-laboratories-new-rd-facility-extends-its-competitive-advantages-and-prepares-for-large-scale-production/